On this page
Osteopetrosis (AD, benign)
This inherited disorder leads to bones that are too hard and can be prone to fractures. It often presents in childhood or adolescence and typically follows a milder course compared to other forms of osteopetrosis, affecting both males and females equally.
Overview
Osteopetrosis, often referred to as 'marble bone disease', is a group of rare genetic conditions that cause bones to become unusually dense and brittle [PMID:33671184]. In healthy bones, there is a continuous process of old bone being removed (resorption) and new bone being formed. This balance is crucial for bone strength and health. In osteopetrosis, the cells responsible for bone resorption, called osteoclasts, do not function correctly, leading to an accumulation of bone material.
Autosomal dominant benign osteopetrosis (ADBO) is generally the mildest form of the condition. While the bones are denser than usual, this form can sometimes be discovered incidentally on X-rays taken for other reasons. The term 'benign' indicates that it is typically less severe than other types of osteopetrosis, which can have life-threatening complications. However, individuals with ADBO can still experience significant health challenges.
Symptoms & clinical features
The symptoms of autosomal dominant benign osteopetrosis can vary widely among individuals, even within the same family. Some people may have no noticeable symptoms, while others experience recurrent fractures. Bone pain is also a common complaint, particularly in the back, hips, and knees [PMID:30557451].
Other potential symptoms include carpal tunnel syndrome, which results from compression of nerves in the wrist, and osteomyelitis (bone infection), especially in the jaw. Dental issues may also be observed, such as delayed tooth eruption, malocclusion (misalignment of teeth), and increased risk of dental caries. Although rarer, some individuals might experience cranial nerve compression due to the increased bone density in the skull, potentially leading to issues with vision or hearing.
Video: Genetics 101
Affected organs
The primary organ system affected in osteopetrosis is the skeletal system, including all bones in the body. The abnormal density can lead to various complications. For example, the increased thickness of bones in the skull can narrow the openings through which nerves and blood vessels pass, potentially affecting the eyes, ears, and other functions controlled by cranial nerves.
Bone marrow, located within bones, can also be affected. In severe forms of osteopetrosis, the bone marrow space can be reduced, impacting the production of blood cells. However, in autosomal dominant benign osteopetrosis, this is less common or typically milder. The jaw bones are often particularly susceptible to infection (osteomyelitis) and other dental problems due to the altered bone structure.
Risks & severity
Autosomal dominant benign osteopetrosis is typically considered a milder form of the condition, but severity can vary considerably. Many individuals may only experience mild symptoms or have the condition discovered incidentally. However, a significant risk is recurrent bone fractures, which can occur from minimal trauma due to the bones being dense but brittle [PMID:33671184]. The risk of fractures can persist throughout life.
Age of onset is variable; symptoms often appear in childhood or adolescence, but some individuals may not be diagnosed until adulthood. While generally not life-threatening, the long-term impact can include chronic pain and reduced mobility due to repeated fractures. There is also an increased risk of osteomyelitis, particularly in the mandible (jawbone), and potential for nerve compression .
Genetic causes
Autosomal dominant benign osteopetrosis is primarily caused by pathogenic variants in the CLCN7 gene. This gene provides instructions for making a protein that functions as a chloride channel, specifically involved in the process of bone resorption. The CLCN7 protein is essential for the proper acidification of the osteoclast 'resorption lacuna', a crucial step for breaking down bone mineral.
When there are pathogenic variants in CLCN7, the chloride channel does not function correctly, which impairs the ability of osteoclasts to resorb bone effectively. This leads to an imbalance where new bone is formed, but old bone is not adequately removed, resulting in excessively dense and brittle bones. Other genes can cause different forms of osteopetrosis, but CLCN7 is the main gene associated with the autosomal dominant benign type.
- CLCN7 Cl-/H+ antiporter 7
Inheritance pattern
Autosomal dominant benign osteopetrosis follows an autosomal dominant inheritance pattern. This means that a person only needs one copy of the altered gene in each cell to develop the condition. Typically, an affected individual inherits the pathogenic variant from one affected parent.
Each child of an individual with autosomal dominant benign osteopetrosis has a 50% (1 in 2) chance of inheriting the altered gene and therefore developing the condition. The condition affects males and females equally. In some rare cases, a new pathogenic variant (de novo mutation) can occur in an individual with no family history of the condition.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of autosomal dominant benign osteopetrosis often begins with clinical suspicion based on symptoms like recurrent fractures or increased bone density noted on X-rays. A definitive diagnosis is typically confirmed through genetic testing, which identifies pathogenic variants in the CLCN7 gene. This testing is usually arranged by a clinical genetics service.
In the UK, individuals suspected of having a genetic bone disorder like osteopetrosis may be referred for genomic testing. This falls under the NHS Genomic Medicine Service, and testing would typically be requested using specific R-codes for skeletal dysplasias. A genetic counsellor or clinical geneticist can provide guidance on the appropriate testing pathway and interpret the results.
Management & lifestyle
Management of autosomal dominant benign osteopetrosis is focused on addressing symptoms and preventing complications, as there is currently no cure for the underlying genetic cause. This typically involves a multidisciplinary team approach, including orthopaedic specialists, pain management teams, and sometimes neurologists or dentists. Regular monitoring for fractures and nerve compression is often recommended.
For recurrent fractures, appropriate orthopaedic care is essential. Dental health should be closely monitored, with regular dental check-ups to manage potential issues like osteomyelitis of the jaw. Physical therapy can be beneficial to maintain mobility and muscle strength. Genetic counselling is an important part of management, offering information and support to affected individuals and their families regarding inheritance patterns and family planning options.
UK care pathway
In the UK, individuals with suspected genetic conditions like osteopetrosis are typically referred to a clinical genetics service. This service can provide a diagnosis through genomic testing, which is part of the NHS Genomic Medicine Service. The testing for skeletal dysplasias, including osteopetrosis, is usually requested using specific R-codes available through the NHS National Genomic Test Directory. Genetic counsellors play a vital role in explaining the condition, its inheritance, and implications for family members.
Frequently asked questions
Are there different types of osteopetrosis?
Yes, there are several types of osteopetrosis, categorised by their inheritance pattern and severity. Autosomal dominant benign osteopetrosis is usually the mildest, while autosomal recessive forms are typically more severe and can have earlier onset with more serious complications.
Can children inherit this condition even if their parents don't have it?
It is possible, though less common. In some cases, a new pathogenic variant (called a 'de novo' mutation) can occur in the CLCN7 gene in a child, even if neither parent has the condition. However, it is more commonly inherited from an affected parent.
What kind of doctors treat osteopetrosis?
Management often involves a team of specialists. This may include orthopaedic surgeons for fractures, neurologists for nerve-related issues, dentists for dental problems, and pain management specialists. Genetic counsellors are also important for understanding the condition and its implications.
Does osteopetrosis affect life expectancy?
Autosomal dominant benign osteopetrosis is generally not associated with a reduced life expectancy, unlike some of the more severe forms of the condition. However, complications like recurrent fractures or infections can impact quality of life and may require ongoing medical attention.